BIO.NRW organises 7th Business Angel Congress in Düsseldorf

„The 7th International Business Angel Congress” (BAC) of BIO.NRW and the EIT Health Investors Network saw again far more than 110 investors, VCs and BAs, founders and CEOs of start-ups participating and respectively presenting.

The “art of financing and being financed in life sciences” BAC focused on case reports and success stories of financing out of NRW and Europe, as well as on personal insights of BAs and VCs financing strategies.

Jan-Philipp Beck, CEO of EIT Health, addressed the next steps of financing and connecting the European innovation eco-systems; he joined the discussion on an ideal investment process (see picture below).

Dr. Bernward Garthoff, Moderator, Chair of Cluster Biotechnology North Rhine-Westphalia, Düsseldorf

Dr. Michael Brandkamp, CEO, High-Tech Management GmbH, Bonn

Jan Philipp Beck, CEO, EIT Health e.V., Munich

Prof. Dr. Detlev Riesner, Private Investor, BIO.NRW Business Angel Circle, Düsseldorf

Dr. Markus Kostka, Director, Investment Manager of the Boehringer Ingelheim Venture Fund, Ingelheim.

Prof. Dr. Gunther Hartmann, Institute for Chemical and Clinical Pharmacology, University Bonn and Rigontec.)

More information about BIO.NRW can be found on the official website

bio.nrw.de

Back to top
Image of

Close